120 related articles for article (PubMed ID: 20213798)
41. PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
Farma JM; Santillan AA; Melis M; Walters J; Belinc D; Chen DT; Eikman EA; Malafa M
Ann Surg Oncol; 2008 Sep; 15(9):2465-71. PubMed ID: 18551347
[TBL] [Abstract][Full Text] [Related]
42. Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer.
Dirisamer A; Halpern BS; Flöry D; Wolf F; Beheshti M; Mayerhoefer ME; Langsteger W
Eur J Radiol; 2010 Feb; 73(2):294-9. PubMed ID: 19181468
[TBL] [Abstract][Full Text] [Related]
43. Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings.
Picchio M; Treiber U; Beer AJ; Metz S; Bössner P; van Randenborgh H; Paul R; Weirich G; Souvatzoglou M; Hartung R; Schwaiger M; Piert M
J Nucl Med; 2006 Jun; 47(6):938-44. PubMed ID: 16741302
[TBL] [Abstract][Full Text] [Related]
44. 18F-fluorodeoxyglucose positron emission tomography-computed tomography for suspected recurrent papillary thyroid cancer: early experience at Sunnybrook Health Sciences Centre.
Dahele M; Ung YC; Ehrlich L; Silverberg J; Balogh J; Wong CS
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):712-7. PubMed ID: 19128681
[TBL] [Abstract][Full Text] [Related]
45. Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography.
Roedl JB; Harisinghani MG; Colen RR; Fischman AJ; Blake MA; Mathisen DJ; Mueller PR
Ann Thorac Surg; 2008 Oct; 86(4):1131-8. PubMed ID: 18805147
[TBL] [Abstract][Full Text] [Related]
46. Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer.
Xu N; Wang M; Zhu Z; Zhang Y; Jiao Y; Fang W
Chin Med J (Engl); 2014; 127(4):607-13. PubMed ID: 24534208
[TBL] [Abstract][Full Text] [Related]
47. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
[TBL] [Abstract][Full Text] [Related]
48. Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer.
Lardinois D; Weder W; Roudas M; von Schulthess GK; Tutic M; Moch H; Stahel RA; Steinert HC
J Clin Oncol; 2005 Oct; 23(28):6846-53. PubMed ID: 16192576
[TBL] [Abstract][Full Text] [Related]
49. [Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
Strunk H; Bucerius J; Jaeger U; Joe A; Flacke S; Reinhardt M; Hortling N; Palmedo H
Rofo; 2005 Sep; 177(9):1235-41. PubMed ID: 16123869
[TBL] [Abstract][Full Text] [Related]
50. Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma.
Falk MS; Truitt AK; Coakley FV; Kashani-Sabet M; Hawkins RA; Franc B
Nucl Med Commun; 2007 Apr; 28(4):273-80. PubMed ID: 17325590
[TBL] [Abstract][Full Text] [Related]
51. Positron emission tomography may underestimate the extent of thoracic disease in lung cancer patients.
Carnochan FM; Walker WS
Eur J Cardiothorac Surg; 2009 May; 35(5):781-4; discussion 784-5. PubMed ID: 19272791
[TBL] [Abstract][Full Text] [Related]
52. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
[TBL] [Abstract][Full Text] [Related]
53. The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer.
Davey K; Heriot AG; Mackay J; Drummond E; Hogg A; Ngan S; Milner AD; Hicks RJ
Dis Colon Rectum; 2008 Jul; 51(7):997-1003. PubMed ID: 18461399
[TBL] [Abstract][Full Text] [Related]
54. In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.
Wild D; Eyrich GK; Ciernik IF; Stoeckli SJ; Schuknecht B; Goerres GW
J Craniomaxillofac Surg; 2006 Jan; 34(1):9-16. PubMed ID: 16343913
[TBL] [Abstract][Full Text] [Related]
55. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
Tuncel M; Souvatzoglou M; Herrmann K; Stollfuss J; Schuster T; Weirich G; Wester HJ; Schwaiger M; Krause BJ
Nucl Med Biol; 2008 Aug; 35(6):689-95. PubMed ID: 18678354
[TBL] [Abstract][Full Text] [Related]
56. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A
BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
[TBL] [Abstract][Full Text] [Related]
57. Role of positron emission tomography in management of sinonasal neoplasms--a single institution's experience.
Lamarre ED; Batra PS; Lorenz RR; Citardi MJ; Adelstein DJ; Srinivas SM; Scharpf J
Am J Otolaryngol; 2012; 33(3):289-95. PubMed ID: 21925763
[TBL] [Abstract][Full Text] [Related]
58. Positron Emission Tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal.
Trautmann TG; Zuger JH
Mol Imaging Biol; 2005; 7(4):309-13. PubMed ID: 16028002
[TBL] [Abstract][Full Text] [Related]
59. Positron emission tomography-computed tomography has a clinical impact for patients with cervical cancer.
Sandvik RM; Jensen PT; Hendel HW; Palle C
Dan Med Bull; 2011 Mar; 58(3):A4240. PubMed ID: 21371401
[TBL] [Abstract][Full Text] [Related]
60. Diagnostic role of (18)F-FDG-PET or PET/CT in salivary gland tumors: A systematic review.
Bertagna F; Nicolai P; Maroldi R; Mattavelli D; Bertoli M; Giubbini R; Lombardi D; Treglia G
Rev Esp Med Nucl Imagen Mol; 2015; 34(5):295-302. PubMed ID: 26488055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]